Guowei W. Zhang
127 Dongming Rd
Zhengzhou, 450003, China
Zhengzhou, 450003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Effectiveness and safety of anlotinib combination regimens in patients with previously immunotherapy treated advanced non-small cell lung cancer
Journal: Zhonghua yi xue za zhi
Published: November 30, 2025
Sintilimab with two cycles of chemotherapy for the treatment of advanced squamous non-small cell lung cancer: a phase 2 clinical trial.
Journal: Nature communications
Published: August 10, 2023
Clinical efficacy and prognosis analysis of treatment regimens for EGFR mutant non-small cell lung cancer and brain metastasis: a retrospective study.
Journal: BMC cancer
Published: November 03, 2022
Efficacy Differences of First-line EGFR-TKIs Alone vs in Combination with Chemotherapy in Advanced Lung Adenocarcinoma Patients with Sensitive EGFR Mutation and Concomitant Non-EGFR Genetic Alterations.
Journal: Zhongguo fei ai za zhi = Chinese journal of lung cancer
Published: September 29, 2022
LncRNA SENCR promotes cell proliferation and progression in non-small-cell lung cancer cells via sponging miR-1-3p.
Journal: Cell cycle (Georgetown, Tex.)
Published: July 05, 2021
Associations between peripheral blood lymphocyte subsets and clinical outcomes in patients with lung cancer treated with immune checkpoint inhibitor.
Journal: Annals of palliative medicine
Published: December 10, 2020
Therapeutic effect of nivolumab on non-small-cell lung cancer patients with brain metastases: a retrospective study
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: December 01, 2020
Influence of genetic variation of programmed death-ligand 1 (PD-L1) on the prognosis of patients with non-small cell lung cancer who received platinum-based adjuvant chemotherapy
Journal: Zhonghua yi xue za zhi
Published: September 14, 2020
Efficacy of first generation EGFR-TKIs and chemotherapy as first-line therapy in advanced lung adenocarcinoma patients with uncommon EGFR mutations
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 26, 2019
Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Journal: Cancer medicine
Published: August 15, 2019
Comparable outcomes of nivolumab in patients with advanced NSCLC presenting with or without brain metastases: a retrospective cohort study.
Journal: Cancer immunology, immunotherapy : CII
Published: March 08, 2019
Efficacy and long-term survival of advanced lung adenocarcinoma patients with uncommon EGFR mutations treated with 1st generation EGFR-TKIs compared with chemotherapy as first-line therapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 15, 2018
Last Updated: 09/26/2026